FDA Approved: KEPPRA XR — Supplemental Application (UCB, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Keppra XR (levetiracetam) from UCB, Inc., resulting in changes to the product labeling. The action pertains to a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• KEPPRA XR (levetiracetam)

Snippet

SUPPL AP for KEPPRA XR (LEVETIRACETAM)